Krilogy Financial’s Zymeworks ZYME Stock Holding History

Krilogy Financial’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$2K	–	702
2018 Q3	$2K	Buy	+100	New	+$1.43K	﹤0.01%	752

Other funds holding ZYME

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Krilogy Financial's ZYME Position: Q4 2018 in Review

Krilogy Financial sold out of Zymeworks (ZYME) in Q4 2018, closing a stake of 100 shares — an estimated $2K sold.

Krilogy Financial first reported a position in ZYME in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 43 funds tracked by Wall St. Rank hold ZYME as of Q4 2018.

Krilogy Financial reported no remaining Zymeworks position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 100 Zymeworks shares in Q4 2018, an estimated $2K.
Krilogy Financial first reported a position in Zymeworks in Q3 2018 and held it in 1 quarter.
Krilogy Financial's Zymeworks position peaked at $2K in Q3 2018.
43 funds tracked by Wall St. Rank held Zymeworks as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.